Hourly refreshSat, Sep 5, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Healthcare

6,687 press releases indexed under healthcare.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Healthcare

INTCO Medical meldet für das erste Halbjahr 2026 ein Umsatzwachstum von 40,6 % und baut die weltweit größte Produktionskapazität für Einweghandschuhe auf 107 Milliarden Stück aus

ZIBO, China, 30. August 2026 /PRNewswire/ -- INTCO Medical („das Unternehmen", 300677.SZ), ein weltweit führender Hersteller von Einweghandschuhen, meldete für die sechs Monate bis zum 30. Juni 2026 einen Umsatz von 6,91 Mrd. RMB (ca. 1,03 Mrd. US-Dollar), ein Plus von 40,61 % gegenüber...

Aug 30 · 03:36PR Newswire
Healthcare

INTCO Medical rapporteert omzetgroei van 40,6% in de eerste helft van 2026, breidt de grootste wegwerphandschoenencapaciteit ter wereld uit tot 107 miljard stuks

ZIBO, China, 30 augustus 2026 /PRNewswire/ -- INTCO Medical ("het bedrijf", 300677.SZ), een toonaangevende wereldwijde fabrikant van wegwerphandschoenen, rapporteerde een omzet van RMB 6,91 miljard (ongeveer USD 1,03 miljard) voor het semester dat eindigt op 30 juni 2026, een stijging van...

Aug 30 · 02:40PR Newswire
Finance · Healthcare

Pomerantz LLP Announces The Filing of a Class Action Litigation Against ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 29, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..

Aug 29 · 22:02PR-Inside
Healthcare

Cunion Frames Its Wearable Health Ecosystem Around Five Health Benefits

San Diego, California--(Newsfile Corp. - August 29, 2026) - Most health technology can overwhelm users with constant notifications and dashboards, eventually causing them to disengage. In response to this challenge, Cunion is building an ecosystem around the premise that the healthiest device is the one that stays quiet until it has something worth saying. From this approach, Cunion identifies five practical health benefits across its wearable ecosystem.To view an enhanced version of this...

Aug 29 · 20:05mlpr-newsfile
Healthcare

Women Leaders Association Adds Lisa Reilly as Boston Coaching Partner, Bringing 23 Years of Biotech Leadership and Her Reclamation Method to High-Achieving Women

The association's Boston Coaching Partners roster grows to three — adding an executive and career coach who helps high-performing women lead with clarity, confidence, and authenticity without sacrificing themselves in the process BOSTON, Aug. 29, 2026 /PRNewswire/ -- The Women Leaders...

Aug 29 · 17:17PR Newswire
Healthcare

Dr. Anita Narang Recognized Among Victoria's Top Optometrists While Advancing the Future of Eye Care

The post Dr. Anita Narang Recognized Among Victoria's Top Optometrists While Advancing the Future of Eye Care first appeared on

Aug 29 · 15:49PRUnderground
Finance · Healthcare

Pomerantz LLP Announces Commencement of Class Action Litigation Against ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 29, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..

Aug 29 · 15:02PR-Inside
SaaS · Healthcare

Meant Earns LegitScript Certification for Its Online GLP-1 Weight Care Platform

MANASSAS, Va., Aug. 29, 2026 /PRNewswire/ -- Meant has earned LegitScript certification for its online GLP-1 weight-care platform, a step that reinforces the transparency behind how the service connects patients with licensed U.S. clinical oversight, private Care Coach support and ongoing...

Aug 29 · 15:00PR Newswire
Finance · Healthcare

Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026

Additional Results from ACACIA-HCM Demonstrate Improvements in Cardiac Structure and Diastolic Function in Patients with Non-Obstructive HCM

Aug 29 · 14:30GlobeNewswire
Healthcare

Bionic Bloom Integrated Health Welcomes Kathryn Silver, MA, RMHCI as New Art Therapy Provider

Experienced art therapist expands access to creative, trauma-informed care for adults, adolescents and families

Aug 29 · 11:00Newswire.com
Finance · Healthcare

INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces

ZIBO, China, Aug. 29, 2026 /PRNewswire/ -- INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit...

Aug 29 · 01:58PRWeb
Healthcare

Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera

MIMRYLO ™ is the First and Only Hepcidin Mimetic Peptide Therapy Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera, Offering a Novel Mechanism to Maintain Hematocrit Control, Meaningfully Reduce Phlebotomy Burden, and Improve Fatigue Approval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Response During Weeks 20-32 FDA Approval Triggers $275M in Milestones, 14%-29% Royalties, with Up to an Additional $875M in Potential Future Milestones Investor call to be held Monday, August 31st at 8:30 am ET

Aug 29 · 00:30Newswire.com
← Prev123558Next →